| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1099718007 |
| P356 | DOI | 10.1186/S12865-017-0236-6 |
| P932 | PMC publication ID | 5735914 |
| P698 | PubMed publication ID | 29258420 |
| P50 | author | Louisa Kühne | Q59708083 |
| P2093 | author name string | Bernhard Banas | |
| Petra Ruemmele | |||
| Bettina Jung | |||
| Tobias Bergler | |||
| Simone Wurm | |||
| Antonia Schuster | |||
| Helen Poth | |||
| P2860 | cites work | Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. | Q51942451 |
| One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation | Q56907959 | ||
| Development of immunoglobulin and antibody-synthesizing cells after immunization with different doses of antigen | Q57339622 | ||
| Chronic Rejection Triggers the Development of an Aggressive Intragraft Immune Response through Recapitulation of Lymphoid Organogenesis | Q59387561 | ||
| Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis | Q80706974 | ||
| Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection | Q81395004 | ||
| Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study | Q82297383 | ||
| Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence | Q82496190 | ||
| Abnormal high expression of B-cell activating factor belonging to the TNF superfamily (BAFF) associated with long-term outcome in kidney transplant recipients | Q84104588 | ||
| De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure | Q84752864 | ||
| Toll-like receptor 4 in experimental kidney transplantation: early mediator of endogenous danger signals | Q85503258 | ||
| TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease | Q22254041 | ||
| Naive T Cell Recruitment to Nonlymphoid Tissues: A Role for Endothelium-Expressed CC Chemokine Ligand 21 in Autoimmune Disease and Lymphoid Neogenesis | Q28198814 | ||
| A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus | Q28254310 | ||
| BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies | Q28272813 | ||
| Intragraft expression of the IL-10 gene is up-regulated in renal protocol biopsies with early interstitial fibrosis, tubular atrophy, and subclinical rejection | Q33745148 | ||
| Ectopic B-cell clusters that infiltrate transplanted human kidneys are clonal | Q33849715 | ||
| Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation | Q34124202 | ||
| Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. | Q34181871 | ||
| Fibrosis with inflammation at one year predicts transplant functional decline. | Q34457101 | ||
| Comprehensive morphometric analysis of mononuclear cell infiltration during experimental renal allograft rejection | Q34522840 | ||
| Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation | Q34901573 | ||
| Lymphoid neogenesis in chronic inflammatory diseases. | Q36405080 | ||
| Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival. | Q36514864 | ||
| Transplant glomerulopathy | Q37092282 | ||
| B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor. | Q37781397 | ||
| A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system. | Q38099139 | ||
| Through a glass darkly: seeking clarity in preventing late kidney transplant failure | Q38237365 | ||
| Characterization of intra-graft B cells during renal allograft rejection | Q38426194 | ||
| Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. | Q39904553 | ||
| Kidney graft survival in Europe and the United States: strikingly different long-term outcomes | Q42672441 | ||
| The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome | Q43050637 | ||
| Donor-Specific HLA Antibody IgG Subclasses Are Associated with Phenotypes of Antibody-Mediated Rejection in Sensitized Renal Allograft Recipients | Q43110440 | ||
| Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts | Q43890254 | ||
| The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy | Q44378940 | ||
| Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients | Q45016042 | ||
| Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide | Q45090832 | ||
| Outcome predictors in African-American deceased-donor renal allograft recipients | Q46134308 | ||
| De novo donor specific antibodies and patient outcomes in renal transplantation | Q46293237 | ||
| Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. | Q46655434 | ||
| Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis | Q47274470 | ||
| Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. | Q48005087 | ||
| Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model | Q48084384 | ||
| Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome. | Q50748403 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking. | Q51805085 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 52 | |
| P577 | publication date | 2017-12-19 | |
| P1433 | published in | BMC Immunology | Q2877163 |
| P1476 | title | Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy | |
| P478 | volume | 18 |
| Q92029916 | IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma |
| Q64118786 | Psychosocial Assessment of Candidates for Transplantation (PACT) Score Identifies High Risk Patients in Pediatric Renal Transplantation |
| Q89947007 | Regulatory CD8 T cells that recognize Qa-1 expressed by CD4 T-helper cells inhibit rejection of heart allografts |
Search more.